Pei-Jer Chen, MD
National Taiwan University Hospital · National Taiwan University Hospital Taipei, Taiwan
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Pei-Jer Chen, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:34 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05257590 · CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular CarcinomaTaiRx, Inc. · recruiting · Hepatocellular Carcinoma, Advanced Cancer · principal investigator
- N/ANCT03020342 · HBV-host cfDNA as Minimal Residual Tumor Marker for HBV-related HCCNational Taiwan University Hospital · unknown · Carcinoma, Hepatocellular · principal investigator
- Ph2NCT02006030 · Ph 2 Trial of ADI PEG 20 Plus Concurrent Transarterial Chemoembolization (TACE) Vs TACE Alone in Patients With Unresectable Hepatocellular CarcinomaPolaris Group · completed · Unresectable Hepatocellular Carcinoma · principal investigator
- Ph3NCT01402908 · A Phase III PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related HCC After Surgical ResectionCellxpert Biotechnology Corp. · terminated · Cancer, Liver Cancer, Hepatocellular Carcinoma · principal investigator
- N/ANCT00635310 · Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With VasopressinNational Taiwan University Hospital · unknown · Chronic Hepatitis C, Chronic Hepatitis B, Biopsy · principal investigator
- Ph4NCT00532701 · Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVRNational Taiwan University Hospital · completed · Chronic Hepatitis C · principal investigator
- Ph4NCT00495131 · Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-infected PatientsNational Taiwan University Hospital · completed · Hepatitis C, Chronic · study director
- Ph2NCT00247728 · PI-88 in Hepatocellular Carcinoma After HepatectomyCellxpert Biotechnology Corp. · completed · Carcinoma, Hepatocellular · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.